Business News

Clondalkin Group Appoints David Lennon Global CEO of Pharmaceutical and Healthcare Division

Friday 01. February 2013 - Clondalkin Group has appointed David Lennon as Global CEO of the international packaging group's growing Pharmaceutical and Healthcare Division.

David will spearhead the roll-out of Clondalkin’s ambitious global business development plans working closely with the European and North American management teams.
The division has invested almost $300 million over the last five years to better service its extensive global pharma and healthcare customer base – and has experienced continued growth over that period as a result. Strategic plans are in place to significantly increase the geographical footprint and widen the current product offering during the next phase of development.
Having joined Clondalkin in 2009 as CEO of the European Pharma and Healthcare division, Mr. Lennon was responsible for the expansion of accredited pharmaceutical packaging facilities from three to eight sites through organic development and strategic acquisition. During this time the platform for continued development was paved by the creation of a world class management structure through the careful appointment of experienced senior executives.
Commenting on the appointment Clondalkin Group Chief Executive, Norbert McDermott said; “We appointed David in 2009 because his pedigree as a senior executive as well as his packaging business expertise was clear. In his four years with Clondalkin Group he has continued to prove himself to be an invaluable leader in consolidating our position as a leading producer of secondary pharmaceutical packaging where we now operate from 18 sites in North America and Europe.
“I am delighted to have David heading up the global development strategy of our Pharmaceutical and Healthcare Division and am confident of our continued success.”
David said; “I am honoured to be invited to lead our pharma and healthcare businesses on both sides of the Atlantic while we continue on the path to global expansion. Clondalkin supplies leading packaging products and solutions to global customers. We think and we act globally. Our commitment to world class product functionality, quality, service and innovation means we are the right choice for customers who require leading-edge pharmaceutical packaging solutions and our increasing global reach makes us a logical choice from a logistics perspective.”
Clondalkin Group operates in a wide range of packaging product sectors across international markets with over 40 production facilities in Europe and North America. The Pharmaceutical and Healthcare division provides precision packaging supply solutions to some of the world’s leading brands.